Akanda (AKAN) Liabilities and Shareholders Equity (2020 - 2025)

Akanda (AKAN) recorded quarterly Liabilities and Shareholders Equity of $6.2 million in Q2 2025, down 21.47% quarter-over-quarter from $7.9 million in Q4 2024, and down 37.63% on a YoY basis from $10.0 million in Q2 2024.

Akanda (AKAN) Liabilities and Shareholders Equity (2020 - 2025) Analysis & Trends

Akanda's Liabilities and Shareholders Equity history runs 6 years deep, the most recent figure standing at $6.2 million for Q2 2025.

  • In Q2 2025, Liabilities and Shareholders Equity fell 37.63% year-over-year to $6.2 million; the TTM figure through Jun 2025 stood at $32.9 million (down 65.08% YoY), while the FY2024 annual figure was $7.9 million, down 10.47% from the prior year.
  • Liabilities and Shareholders Equity was $6.2 million for Q2 2025 at Akanda, down from $7.9 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $43.5 million in Q2 2022 to a low of $6.2 million in Q2 2025.
  • Historically, Liabilities and Shareholders Equity has averaged $20.0 million across 5 years, with a median of $9.4 million in 2023.
  • The sharpest annual moves came in 2022 and 2023: Liabilities and Shareholders Equity surged 384.67% in 2022, then slumped 77.33% in 2023.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $8.0 million in 2021, then soared by 384.67% to $39.0 million in 2022, then plunged by 77.33% to $8.8 million in 2023, then dropped by 10.47% to $7.9 million in 2024, then fell by 21.47% to $6.2 million in 2025.
  • The last three Liabilities and Shareholders Equity figures came in at $6.2 million (Q2 2025), $7.9 million (Q4 2024), and $10.0 million (Q2 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 40.04 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 15.15 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 6.71 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 555.95 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 4.91 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 13.22 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 4.26 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 2.27 Bn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 2.35 Bn
10 Akanda 826.99 Mn 824.46 Mn - 6.20 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 6.20 Mn
Jun 30, 2025 6.22 Mn
Dec 31, 2024 7.91 Mn
Jun 30, 2024 9.97 Mn
Dec 31, 2023 8.84 Mn
Jun 30, 2023 36.51 Mn
Dec 31, 2022 39.00 Mn
Jun 30, 2022 43.48 Mn
Dec 31, 2021 8.05 Mn
Dec 31, 2020 4.27 Mn